SCHEMBL27199804

SCHEMBL27199804

COc1ccc(Nc2nc3ccncc3c3[nH]c4ccncc4c23)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LATS1 O95835 1/20 0.50
▸ ACHE P22303 1/20 0.45
▸ ABCG2 Q9UNQ0 4/20 0.45
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ ABCC1 P33527 1/20 0.45
▸ PTK6 Q13882 1/20 0.44
▸ NPY5R Q15761 1/20 0.44
▸ MAPT P10636 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ TLR3 O15455 1/20 0.43
▸ NR3C1 P04150 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ KIT P10721 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ ADORA3 P0DMS8 1/20 0.42
▸ ADORA1 P30542 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27199806 0.87 LATS1 (0.47) LATS1ACHEABCG2MEN1KMT2A
SCHEMBL27199812 0.87 CSNK2A1 (0.53) ACHEABCG2MEN1KMT2APTK6
SCHEMBL27199810 0.85 CSNK2A2 (0.47) ABCG2NPY5RKDM4EPKMRAB9A
SCHEMBL27199813 0.84 KDM1A (0.45) MEN1KMT2AMAPTKDM4EPKM
SCHEMBL27171380 0.80 KMT2A (0.45) LATS1ACHEABCG2MEN1KMT2A
SCHEMBL31485594 0.80 LATS1 (0.56) LATS1ABCG2MEN1KMT2AABCC1
SCHEMBL27074286 0.79 CSNK2A1 (0.57) CLK1CLK2CLK3CDK5DYRK1A
SCHEMBL27199809 0.79 TGFBR1 (0.40) LATS1ACHEMEN1KMT2AMAPT
SCHEMBL27199801 0.79 LATS1 (0.51) LATS1ACHEABCG2MAPTKIT
SCHEMBL27092621 0.78 LATS1 (0.51) LATS1ACHEABCG2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11964976-B1 Substituted pyrido[3′,4′:4,5]pyrrolo[3,2-c][1,6]naphthyridines as CK2 inhibitors King Faisal University (SA) 2024-04-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11964976-B1 Substituted pyrido[3′,4′:4,5]pyrrolo[3,2-c][1,6]naphthyridines as CK2 inhibitors CKS2, CDK2, CDK1 LATS1 974/4885ACHE 606/4885ABCG2 2679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback